Search

Search Constraints

You searched for: Author/Creator You, B

Search Results

1. 164 ENGOT-cx11/GOG 3047/KEYNOTE-A18: a phase 3, randomized, double-blind study of pembrolizumab with chemoradiotherapy in patients with high-risk locally advanced cervical cancer. (13th November 2020)

3. 44PCorrelation between an automated functional assay that predicts targeted agent (TA) sensitivity and the tumor response of the sorafenib treatment evaluated within the MOST clinical trial. (16th September 2018)

4. 972PBcl-2 proteins expression and response to navitoclax in platinum resistant/refractory recurrent ovarian cancer (PROC). (23rd October 2018)

7. Modeling and predicting optimal treatment scheduling between the antiangiogenic drug sunitinib and irinotecan in preclinical settings. (11th December 2015)

8. Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trial. (13th March 2019)